12 , 13 , 14 , 15 , 16 , 17 We assessed the impact of age at uveitis onset on recurrence risk and observed a nonsignificant trend toward higher risk in younger patients across the entire cohort.
← all excerpts
Recurrence Risk in Pediatric Noninfectious Uveitis During Adalimumab Tapering: An International Multicenter Retrospective Study.
2
—
—
The sentences
On the other hand, patients who discontinued TNFi without tapering exhibited an increasing trend in disease activity and had minimal radiographic progression. 23 In conclusion, our multicenter study clearly showed that the modality of ADA tapering exerts a great clinical impact on the risk of uveitis recurrence: it is recommended to taper ADA gradually and with a slow schedule, maintaining a strict follow‐up given the high rate of relapse.